The epidemic situation on hepatitis A in the North-West of Russia during the COVID-19 pandemic in 2021
https://doi.org/10.34680/2076-8052.2022.4(129).46-50
Abstract
The COVID-19 pandemic has become a major burden on the global health system and has had a significant impact on other global programs, including monitoring, screening, and elimination of hepatitis A. Considering several possible ways of transmission of SARS-CoVi-2 and due to its diverse effects on the body, it is important to study and differentiate the impact of COVID-19 on the epidemiology and course of other diseases, including hepatitis A. The aim of the work is to characterize the epidemic situation of hepatitis A in the North-West of Russia during the COVID-19 pandemic in 2021. The data of the state statistical reporting of Rospotrebnadzor obtained from the internal databank based on daily regional reports, as well as analytical tables developed by specialists of the Scientific and Methodological Center for Epidemiological Surveillance of Viral Hepatitis of the St. Petersburg Pasteur Institute and the Reference Center for Monitoring Viral Hepatitis of the Central Research Institute of Epidemiology of Rospotrebnadzor were analyzed. There was a clear decrease in the incidence of hepatitis A in the period from 2008 to 2021. In 2020 and 2021, in the context of the COVID-19 pandemic, the incidence of hepatitis A in the North-West of Russia reached the lowest values: 2.0 and 1.3 per 100,000 population. It is possible that the restrictive measures introduced to combat coronavirus infection led to the interruption of the common transmission routes of SARS-CoVi-2 and hepatitis A virus, helping to reduce the incidence.
About the Authors
E. N. Priima
Санкт-Петербургский государственный педиатрический медицинский университет
Russian Federation
Russian Federation
M. Yu. Butskaya
Санкт-Петербургский государственный педиатрический медицинский университет; Санкт-Петербургский научно-исследовательский институт эпидемиологии и микробиологии им. Пастера
Russian Federation
Russian Federation
Zh. O. Dobrova
Санкт-Петербургский государственный педиатрический медицинский университет
Russian Federation
Russian Federation
References
1. Belyh N.A., Solov'eva O.A., Anikeeva N.A. Epidemiologicheskie i kliniko–laboratornye osobennosti COVID–19 u pacientov detskogo vozrasta [Epidemiological and clinical and laboratory features of COVID-19 in pediatric patients]. Pediatr — Pediatrician, 2021, vol.12, no.6, pp.63–76. doi: https://doi.org/10.17816/PED12663-76
2. Belyakov N.A., Boeva E.V., Simakina O. E., et al. Pandemiya COVID–19 i ee vliyanie na techenie drugikh infektsiy na Severo–Zapade Rossii [The COVID-19 pandemic and its impact on the course of other infections in the North-West of Russia]. VICH–infekciya i immunosupressii — HIV infection and Immunosuppressive Disorders, 2022, vol.14, no.1, pp.7–24. doi: https://doi.org/10.22328/2077-9828-2022-14-1-7-24
3. Mikhaylov M. I., Kyuregyan K. K. Sovremennaya strate-giya kontrolya virusnogo gepatita A v Rossiyskoy Federatsii [Modern strategy for the control of viral hepatitis A in the Russian Federation]. Zhurnal mikrobiologii, epidemiologii I immunobiologii — Journal of Microbiology, Epidemiology and Immunobiology, 2021, vol.98, no.2, pp.190–197. doi: https://doi.org/10.36233/0372-9311-103
4. Pshenichnaya N. Yu., Veselova E. I., Semenov D. A., et al. COVID-19 — novaya global'naya ugroza chelovechestvu [COVID-19 is a new global threat to humanity]. Epidemiologiya i infektsionnyye bolezni. Aktual'nyye voprosy — Epidemiology and Infectious Diseases. Current Items, 2020, vol.10, no.1, pp.6–13. doi: https://doi.org/10.18565/epidem.2020.10.1.6-13
5. Karpova L.S., Stolyar K. A., Popovceva N. M., Stolyarova T. P., Danilenko D. M. Sravnenie pervyh trekh voln pandemii COVID–19 v Rossii (2020–2021 gg.) [Comparison of the first three waves of the COVID-19 pandemic in Russia (2020–2021)]. Epidemiologiya i vakcinoprofilaktika — Epidemiology and Vaccinal Prevention, 2022, vol.21(2), pp.4–16. doi: https://doi.org/10.31631/2073-3046-2022-21-2-4-16
6. Kasyanenko K.V., Maltsev O.V., Kozlov K.V., et al. Otsenka profilakticheskoy effektivnosti i bezopasnosti azoksimera bromida u meditsinskikh rabotnikov, nakhodyashchikhsya v kontakte s patsiyentami, gospita-lizirovannymi po povodu COVID-19 [Evaluation of the preventive efficacy and safety of azoximer bromide in healthcare workers in contact with patients hospitalized for COVID-19]. Epidemiologiya I vakcinoprofilaktika — Epidemiology and Vaccinal Prevention, 2022, vol.21, no.1, pp.67–73. doi: https://doi.org/10.31631/2073-3046-2022-21-1-67-73
7. Esaulenko E.V., Sukhoruk A.D., Bushmanova A.D., et al. Epidemiologicheskiye i molekulyarno-geneticheskiye osobennosti enteral'nykh virusnykh gepatitov v Rossii na sovremennom etape [Epidemiological and molecular genetic features of enteral viral hepatitis in Russia at the present stage]. Al'manakh klinicheskoy meditsiny — Almanac of Clinical Medicine, 2018, vol.46, no.1, pp.50–58. doi: https://doi.org/10.18786/2072-0505-2018-46-1-50-58
8. Abutaleb A, Kottilil S. Hepatitis A: Epidemiology, Natural History, Unusual Clinical Manifestations, and Prevention. Gastroenterol. Clin. North. Am., 2020, vol.49(2), pp.191–199. doi: https://doi.org/10.1016/j.gtc.2020.01.002
9. Gladkikh, A.; Dedkov, V.; Sharova, A.; Klyuchnikova, E.; Sbarzaglia, V.; Kanaeva, O.; Arbuzova, T.; Tsyganova, N.; Popova, A.; Ramsay, E.; Totolian, A. Epidemiological Features of COVID–19 in Northwest Russia in 2021. Viruses, 2022, vol.14, article no.931. doi: https://doi.org/10.3390/v14050931
10. Davies, N.G.; Klepac, P.; Liu, Y.; Prem, K.; Jit, M.; Eggo, R.M.; CMMID COVID–19 working group. Age-dependent effects in the transmission and control of COVID–19 epidemics. Nat. Med., 2020, vol.26, pp.1205–1211. doi: https://doi.org/10.1038/s41591-020-0962-9
11. Butskaya M.Yu., Bushmanova A.D., Priyma E.N., et al. Sovremennyye epidemiologicheskiye aspekty ostrykh virusnykh gepatitov v Rossii [Modern epidemiological aspects of acute viral hepatitis in Russia]. Epidemiologiya i infektsionnyye bolezni — Epidemiology and Infectious Diseases, 2021, vol.26, no.2, pp.67–74. doi: https://doi.org/10.17816/EID105585
12. Mikhaylov M.I., Yushchuk N.D., Malinnikova Ye. YU. Virusnyye gepatity — problema obshchestvennogo zdorov'ya v Rossiyskoy Federatsii (proyekt programmy po kontrolyu i likvidatsii virusnykh gepatitov) [Viral hepatitis is a public health problem in the Russian Federation (draft program for the control and elimination of viral hepatitis)]. ORGZDRAV: novosti, mneniya, obucheniye. Vestnik VSHOUZ — Healthcare Management: News, Views, Education. Bulletin of VSHOUZ, 2018, no.2(12), pp.20–29. doi: https://doi.org/10.24411/2411-8621-2018-12002
13. Virusnyye gepatity v Rossiyskoy Federatsii. Analiticheskiy obzor. 11 vypusk [Viral hepatitis in the Russian Federation. Analytical review. Issue 11]. Eds. V.I. Pokrovsky, A.A. Totolyan. St. Petersburg, Saint-Petersburg Pasteur Institute Publ., 2018. 112 p.
14. Kyuregyan K.K., Ignatieva M.E., Mikhailov M.I. Epidemiologiya i profilaktika gepatita A v stranakh s perekhodnoy ekonomikoy na primere Tsentral'noamerikanskogo regiona [Epidemiology and prevention of hepatitis A in countries with economies in transition on the example of the Central American region]. Infektsionnyye bolezni: novosti, mneniya, obucheniye — Infectious Diseases: News, Opinions, Training, 2019, vol.8, no.3(30), pp.53–60. doi: https://doi.org/10.24411/2305-3496-2019-13009
15. Pisano MB, Giadans CG, Flichman DM, Ré VE, Preciado MV, Valva P. Viral hepatitis update: Progress and perspectives. World J. Gastroenterol., 2021, vol.14, no.27(26), pp.4018–4044. doi: https://doi.org/10.3748/wjg.v27.i26.4018
16. Esaulenko E.V., Bushmanova A.D., Sukhoruk A.D. Clinical and laboratory characteristics of hepatitis A in patients with hepatitis B virus markers [Kliniko-laboratornaya kharakteristika gepatita A u patsiyentov s markerami virusa gepatita B]. Zhurnal infektologii — Journal of Infectology, 2017, vol.9, no.3, pp.75–80. doi: https://doi.org/10.22625/2072-6732-2017-9-3-75-80
17. Torre P, Aglitti A, Masarone M, Persico M. Viral hepatitis: Milestones, unresolved issues, and future goals. World J. Gastroenterol., 2021, vol.27(28), pp.4603–4638. doi: https://doi.org/10.3748/wjg.v27.i28.4603
18. Martínez Lozano H, Conthe Alonso A, Bañares R. A new pattern in hepatitis A virus infection in an urban population. Rev. Esp. Enferm. Dig., 2020, vol.112(3), pp.178–182. doi: https://doi.org/10.17235/reed.2020.6526/2019
Review
For citations:
Priima E.N., Butskaya M.Yu., Dobrova Zh.O. The epidemic situation on hepatitis A in the North-West of Russia during the COVID-19 pandemic in 2021. Title in english. 2022;(4(129)):46-50. (In Russ.) https://doi.org/10.34680/2076-8052.2022.4(129).46-50
Views:
51
Email this article 